Health status and quality of life in tuberculosis

International Journal of Infectious Diseases

Volumn 32, Issue , 2015, Pages 68-75

  Brown, James ^a   Capocci, Santino ^a   Smith, Colette ^a   Morris, Steve ^a   Abubakar, Ibrahim ^a   Lipman, Marc ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Health economics; Health status; Measures of health; Quality of life; Tuberculosis

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DISABILITY; ENDEMIC DISEASE; EVALUATION STUDY; EXTRAPULMONARY TUBERCULOSIS; HEALTH STATUS; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MIXED INFECTION; MULTIDRUG RESISTANT TUBERCULOSIS; POPULATION RESEARCH; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; TUBERCULOSIS; ADULT; CHILD; COMPLICATION; FEMALE; MORBIDITY;

ADULT; CHILD; COINFECTION; FEMALE; HEALTH STATUS; HIV INFECTIONS; HUMANS; MORBIDITY; QUALITY OF LIFE; TUBERCULOSIS;

EID: 84925257708     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2014.12.045     Document Type: Review

References (70)

1. Hershkovitz I., Donoghue H.D., Minnikin D.E., Besra G.S., Lee O.Y., Gernaey A.M., et al. Detection and molecular characterization of 9,000-year-old Mycobacterium tuberculosis from a Neolithic settlement in the Eastern Mediterranean. PLoS One 2008, 3:e3426.
2. McKenna S.P. Measuring patient-reported outcomes: moving beyond misplaced common sense to hard science. BMC Med 2011, 9:86.
3. Preamble to the Constitution of the World Health Organization as adopted by the International Health Conference NY, 19-22 June, 1946; signed on 22 July 1946 by the representatives of 61 States (Official Records of the World Health Organization, no. 2, p. 100) and entered into force on 7 April 1948.
4. Conrad P., Barker K.K. The social construction of illness: key insights and policy implications. J Health Soc Behav 2010, 51(Suppl):S67-S79.
5. Bauer M., Leavens A., Schwartzman K. A systematic review and meta-analysis of the impact of tuberculosis on health-related quality of life. Qual Life Res 2013, 22:2213-2235.
6. Bauer M., Greenaway C., Lalli M., Leavens A., Wynee A., Vissandjee B., et al. Health-related quality of life in active and latent tuberculosis patients, and a matched comparison group 2011, Annual International Meeting of the American Thoracic Society, Denver.
7. Chang B., Wu A.W., Hansel N.N., Diette G.B. Quality of life in tuberculosis: a review of the English language literature. Qual Life Res 2004, 13:1633-1642.
8. Guo N., Marra C.A., Marra F., Moadebi S., Elwood R.K., Fitzgerald J.M. Health state utilities in latent and active tuberculosis. Value Health 2008, 11:1154-1161.
9. Dion M.J., Tousignant P., Bourbeau J., Menzies D., Schwartzman K. Measurement of health preferences among patients with tuberculous infection and disease. Med Decis Making 2002, 22:S102-S114.
10. World Health Organization. Global tuberculosis report 2014 2014, WHO, Geneva.
11. Dion M.J., Tousignant P., Bourbeau J., Menzies D., Schwartzman K. Feasibility and reliability of health-related quality of life measurements among tuberculosis patients. Qual Life Res 2004, 13:653-665.
12. Kruijshaar M.E., Abubakar I. Increase in extrapulmonary tuberculosis in England and Wales 1999-2006. Thorax 2009, 64:1090-1095.
13. Pasipanodya J.G., Miller T.L., Vecino M., Munguia G., Bae S., Drewyer G., et al. Using the St. George respiratory questionnaire to ascertain health quality in persons with treated pulmonary tuberculosis. Chest 2007, 132:1591-1598.
14. Masumoto S., Yamamoto T., Ohkado A., Yoshimatsu S., Querri A.G., Kamiya Y. Factors associated with health-related quality of life among pulmonary tuberculosis patients in Manila, the Philippines. Qual Life Res 2014, 23:1523-1533.
15. Aydin I.O., Uluşahin A. Depression, anxiety comorbidity, and disability in tuberculosis and chronic obstructive pulmonary disease patients: applicability of GHQ-12. Gen Hosp Psychiatry 2001, 23:77-83.
16. Westaway M.S., Wolmarans L. Depression and self-esteem: rapid screening for depression in black, low literacy, hospitalized tuberculosis patients. Soc Sci Med 1992, 35:1311-1315.
17. Aghanwa H.S., Erhabor G.E. Demographic/socioeconomic factors in mental disorders associated with tuberculosis in southwest Nigeria. J Psychosom Res 1998, 45:353-360.
18. Kruijshaar M.E., Lipman M., Essink-Bot M.L., Lozewicz S., Creer D., Dart S., et al. Health status of UK patients with active tuberculosis. Int J Tuberc Lung Dis 2010, 14:296-302.
19. Marra C.A., Marra F., Colley L., Moadebi S., Elwood R.K., Fitzgerald J.M. Health-related quality of life trajectories among adults with tuberculosis: differences between latent and active infection. Chest 2008, 133:396-403.
20. Rajeswari R., Muniyandi M., Balasubramanian R., Narayanan P.R. Perceptions of tuberculosis patients about their physical, mental and social well-being: a field report from south India. Soc Sci Med 2005, 60:1845-1853.
21. Aggarwal A.N., Gupta D., Janmeja A.K., Jindal S.K. Assessment of health-related quality of life in patients with pulmonary tuberculosis under programme conditions. Int J Tuberc Lung Dis 2013, 17:947-953.
22. Dhingra V.K., Rajpal S. Health related quality of life (HRQL) scoring (DR-12 score) in tuberculosis-additional evaluative tool under DOTS. J Commun Dis 2005, 37:261-268.
23. Balgude A., Sontakke S. Study of impact of antitubercular therapy on quality of life. Indian J Med Sci 2012, 66:71-77.
24. Maguire G.P., Anstey N.M., Ardian M., Waramori G., Tjitra E., Kenangalem E., et al. Pulmonary tuberculosis, impaired lung function, disability and quality of life in a high-burden setting. Int J Tuberc Lung Dis 2009, 13:1500-1506.
25. Chamla D. The assessment of patients' health-related quality of life during tuberculosis treatment in Wuhan, China. Int J Tuberc Lung Dis 2004, 8:1100-1106.
26. Atif M., Sulaiman S.A., Shafie A.A., Asif M., Sarfraz M.K., Low H.C., et al. Impact of tuberculosis treatment on health-related quality of life of pulmonary tuberculosis patients: a follow-up study. Health Qual Life Outcomes 2014, 12:19.
27. Dias A.A., de Oliveira D.M., Turato E.R., de Figueiredo R.M. Life experiences of patients who have completed tuberculosis treatment: a qualitative investigation in southeast Brazil. BMC Public Health 2013, 13:595.
28. Diel R., Rutz S., Castell S., Schaberg T. Tuberculosis: cost of illness in Germany. Eur Respir J 2012, 40:143-151.
29. Tuberculosis: clinical diagnosis and management of tuberculosis, and measures for its prevention and control. National Institute for Health and Care Excellence; 2011.
30. Treatment of tuberculosis: guidelines for national programmes 2010, World Health Organization, WHO, Geneva.
31. Falzon D., Jaramillo E., Schünemann H.J., Arentz M., Bauer M., Bayona J., et al. WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update. Eur Respir J 2011, 38:516-528.
32. Diel R., Vandeputte J., de Vries G., Stillo J., Wanlin M., Nienhaus A. Costs of tuberculosis disease in the European Union: a systematic analysis and cost calculation. Eur Respir J 2014, 43:554-565.
33. Muniyandi M., Rajeswari R., Balasubramanian R., Nirupa C., Gopi P.G., Jaggarajamma K., et al. Evaluation of post-treatment health-related quality of life (HRQoL) among tuberculosis patients. Int J Tuberc Lung Dis 2007, 11:887-892.
34. Ralph A.P., Kenangalem E., Waramori G., Pontororing G.J., Sandjaja, Tjitra E., et al. High morbidity during treatment and residual pulmonary disability in pulmonary tuberculosis: under-recognised phenomena. PLoS One 2013, 8:e80302.
35. Dye C., Glaziou P., Floyd K., Raviglione M. Prospects for tuberculosis elimination. Annu Rev Public Health 2013, 34:271-286.
36. Hsiung P.C., Fang C.T., Chang Y.Y., Chen M.Y., Wang J.D. Comparison of WHOQOL-bREF and SF-36 in patients with HIV infection. Qual Life Res 2005, 14:141-150.
37. Babikako H.M., Neuhauser D., Katamba A., Mupere E. Feasibility, reliability and validity of health-related quality of life questionnaire among adult pulmonary tuberculosis patients in urban Uganda: cross-sectional study. Health Qual Life Outcomes 2010, 8:93.
38. Deribew A., Tesfaye M., Hailmichael Y., Negussu N., Daba S., Wogi A., et al. Tuberculosis and HIV co-infection: its impact on quality of life. Health Qual Life Outcomes 2009, 7:105.
39. Deribew A., Deribe K., Reda A.A., Tesfaye M., Hailmichael Y., Maja T., et al. Change in quality of life: a follow up study among patients with HIV infection with and without TB in Ethiopia. BMC Public Health 2013, 13:408.
40. Dowdy D.W., Israel G., Vellozo V., Saraceni V., Cohn S., Cavalcante S., et al. Quality of life among people treated for tuberculosis and human immunodeficiency virus in Rio de Janeiro, Brazil. Int J Tuberc Lung Dis 2013, 17:345-347.
41. Louw J., Peltzer K., Naidoo P., Matseke G., Mchunu G., Tutshana B. Quality of life among tuberculosis (TB), TB retreatment and/or TB-HIV co-infected primary public health care patients in three districts in South Africa. Health Qual Life Outcomes 2012, 10:77.
42. Isaakidis P., Rangan S., Pradhan A., Ladomirska J., Reid T., Kielmann K. 'I cry every day': experiences of patients co-infected with HIV and multidrug-resistant tuberculosis. Trop Med Int Health 2013, 18:1128-1133.
43. Abubakar I., Zignol M., Falzon D., Raviglione M., Ditiu L., Masham S., et al. Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect Dis 2013, 13:529-539.
44. Pietersen E., Ignatius E., Streicher E.M., Mastrapa B., Padanilam X., Pooran A., et al. Long-term outcomes of patients with extensively drug-resistant tuberculosis in South Africa: a cohort study. Lancet 2014, 383:1230-1239.
45. Godoy M.D., Mello F.C., Lopes A.J., Costa W., Guimarães F.S., Pacheco A.G., et al. The functional assessment of patients with pulmonary multidrug-resistant tuberculosis. Respir Care 2012, 57:1949-1954.
46. Seddon J.A., Godfrey-Faussett P., Jacobs K., Ebrahim A., Hesseling A.C., Schaaf H.S. Hearing loss in patients on treatment for drug-resistant tuberculosis. Eur Respir J 2012, 40:1277-1286.
47. Conradie F., Mabiletsa T., Sefoka M., Mabaso S., Louw R., Evans D., et al. Prevalence and incidence of symmetrical symptomatic peripheral neuropathy in patients with multidrug-resistant TB. S Afr Med J 2014, 104:24-26.
48. Melchionda V., Wyatt H., Capocci S., Garcia Medina R., Solamalai A., Katiri S., et al. Amikacin treatment for multidrug resistant tuberculosis: how much monitoring is required?. Eur Respir J 2013, 42:1148-1150.
49. Bassili A., Fitzpatrick C., Qadeer E., Fatima R., Floyd K., Jaramillo E. A systematic review of the effectiveness of hospital- and ambulatory-based management of multidrug-resistant tuberculosis. Am J Trop Med Hyg 2013, 89:271-280.
50. Marais B.J., Graham S.M., Maeurer M., Zumla A. Progress and challenges in childhood tuberculosis. Lancet Infect Dis 2013, 13:287-289.
51. van Rie A., McCarthy K., Scott L., Dow A., Venter W.D., Stevens W.S. Prevalence, risk factors and risk perception of tuberculosis infection among medical students and healthcare workers in Johannesburg, South Africa. S Afr Med J 2013, 103:853-857.
52. Claassens M.M., van Schalkwyk C., du Toit E., Roest E., Lombard C.J., Enarson D.A., et al. Tuberculosis in healthcare workers and infection control measures at primary healthcare facilities in South Africa. PLoS One 2013, 8:e76272.
53. Nienhaus A., Schablon A., Preisser A.M., Ringshausen F.C., Diel R. Tuberculosis in healthcare workers - a narrative review from a German perspective. J Occup Med Toxicol 2014, 9:9.
54. Biadglegne F., Rodloff A.C., Sack U. Review of the prevalence and drug resistance of tuberculosis in prisons: a hidden epidemic. Epidemiol Infect 2014, 1-14. [Epub ahead of print].
55. Zenner D., Kruijshaar M.E., Andrews N., Abubakar I. Risk of tuberculosis in pregnancy: a national, primary care-based cohort and self-controlled case series study. Am J Respir Crit Care Med 2012, 185:779-784.
56. Sugarman J., Colvin C., Moran A.C., Oxlade O. Tuberculosis in pregnancy: an estimate of the global burden of disease. Lancet Glob Health 2014, 2:e710-e716.
57. Pasipanodya J.G., McNabb S.J., Hilsenrath P., Bae S., Lykens K., Vecino E., et al. Pulmonary impairment after tuberculosis and its contribution to TB burden. BMC Public Health 2010, 10:259.
58. Tsevat J., Taylor W.C., Wong J.B., Pauker S.G. Isoniazid for the tuberculin reactor: take it or leave it. Am Rev Respir Dis 1988, 137:215-220.
59. Porco T.C., Lewis B., Marseille E., Grinsdale J., Flood J.M., Royce S.E. Cost-effectiveness of tuberculosis evaluation and treatment of newly-arrived immigrants. BMC Public Health 2006, 6:157.
60. Miller T.L., McNabb S.J., Hilsenrath P., Pasipanodya J., Weis S.E. Personal and societal health quality lost to tuberculosis. PLoS One 2009, 4:e5080.
61. Salomon J.A., Vos T., Hogan D.R., Gagnon M., Naghavi M., Mokdad A., et al. Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010. Lancet 2012, 380:2129-2143.
62. Diel R., Lampenius N. Cost-effectiveness analysis of interventions for tuberculosis control: DALYs versus QALYs. Pharmacoeconomics 2014, 32:617-626.
63. Wang Y., Lii J., Lu F. [Measuring and assessing the quality of life of patients with pulmonary tuberculosis]. Zhonghua Jie He He Hu Xi Za Zhi 1998, 21:720-723.
64. Bhatia M.S., Bhasin S.K., Dubey K.K. Psychosocial dysfunction in tuberculosis patients. Indian J Med Sci 2000, 54:171-173.
65. Yang L., Wu D.L., Guo H.G., Liu J.W. [A study of the psychological and social factors in patients with pulmonary tuberculosis]. Zhonghua Jie He He Hu Xi Za Zhi 2003, 26:704-707.
66. Stefano Vinaccia J.M.Q., Fernandez H., Elena Perez B., Olga Sanches M., Londono A. Calidad de vida relacionada con la salud y apoyo docial percibido en pacientes con diagnostico de tuberculosis pulmonary. Anales de psicologia 2007, 23:245-252.
67. Unalan D., Soyuer F., Ceyhan O., Basturk M., Ozturk A. Is the quality of life different in patients with active and inactive tuberculosis?. Indian J Tuberc 2008, 55:127-137.
68. Husain M.O., Dearman S.P., Chaudhry I.B., Rizvi N., Waheed W. The relationship between anxiety, depression and illness perception in tuberculosis patients in Pakistan. Clin Pract Epidemiol Ment Health 2008, 4:4.
69. Dhuria M., Sharma N., Narender Pal Singh, Ram Chander Jiloha, Saha R., Gopal Krishan Ingle A study of the impact of tuberculosis on the quality of life and the effect after treatment with DOTS. Asia Pac J Public Health 2009, 21:312-320.
70. Chung W.S., Lan Y.L., Yang M.C. Psychometric testing of the short version of the world health organization quality of life (WHOQOL-BREF) questionnaire among pulmonary tuberculosis patients in Taiwan. BMC Public Health 2012, 12:630.